This may be attributed to the dysregulated immunological status and the exaggerated pro-inflammatory cytokine response, manifesting as higher ratios of lymphopenia and increased levels of neutrophils, serum CRP, and IL-6 in patients with COVID-19 with pre-existing T2D compared to non-diabetic patients (19, 23). The gene discussed is CRP; the disease is type 2 diabetes mellitus.